Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1979 May;63(5):1026–1035. doi: 10.1172/JCI109371

Shortening of the Bleeding Time in Rabbits by Hydrocortisone Caused by Inhibition of Prostacyclin Generation by the Vessel Wall

M A Blajchman 1,2, A F Senyi 1,2, J Hirsh 1,2, Y Surya 1,2, M Buchanan 1,2, J F Mustard 1,2
PMCID: PMC372045  PMID: 376547

Abstract

The effect of hydrocortisone on thrombocytopenic bleeding has been studied in rabbits using a jugular vein bleeding-time technique and a microvascular bleeding-time technique. An inverse relationship was found between the bleeding time and platelet count with both techniques in rabbits made thrombocytopenic by either X-irradiation or injection of heterologous platelet antiserum. Hydrocortisone shortened both bleeding times in thrombocytopenic animals when given in single large doses intravenously (25-100 mg/kg), in daily doses (6 mg/kg) intramuscularly, and shortened the jugular bleeding time when applied to the outside of the jugular vein or instilled intraluminally into the vein. This effect was also noted in normal animals. The effect on thrombocytopenic bleeding was dose related. When given daily, the effect was greater when hydrocortisone was given for 10 d than for 5 d. Both indomethacin and tranylcypromine also reduced the jugular vein bleeding time when instilled intraluminally into the jugular vein, whereas exogenously provided arachidonic acid reversed the effect of hydrocortisone but did not reverse the effect of indomethacin or tranylcypromine. Exogenously provided linoleic acid did not have any effect. Perfusion of the vessel segment with prostacyclin (PGI2) reversed the effect of intraluminally administered hydrocortisone, indomethacin, and tranylcypromine. Similarly, hydrocortisone, indomethacin, and tranylcypromine all reduced the rate of loss of fluid from a standard wound in isolated vessels emptied of blood and perfused with saline under constant pressure. PGI2 reversed the action of these three agents, however, arachidonic acid reversed only the effect of hydrocortisone and did not reverse the effect of indomethacin and tranylcypromine. The generation of PGI2-like material and 6-keto-prostaglandinF1 α from jugular vein strips was prevented by prior exposure of the animals or vessel wall to hydrocortisone. These results are compatible with the hypothesis that the vessel wall releases smooth muscle-relaxing prostaglandins when injured and that inhibition of prostaglandin formation by hydrocortisone enhances hemostasis by allowing vasoconstriction to be maintained.

Full text

PDF
1026

Images in this article

1029Image
on p.1029

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ardlie N. G., Packham M. A., Mustard J. F. Adenosine diphosphate-induced platelet aggregation in suspensions of washed rabbit platelets. Br J Haematol. 1970 Jul;19(1):7–17. doi: 10.1111/j.1365-2141.1970.tb01596.x. [DOI] [PubMed] [Google Scholar]
  2. BRECHER G., CRONKITE E. P. Morphology and enumeration of human blood platelets. J Appl Physiol. 1950 Dec;3(6):365–377. doi: 10.1152/jappl.1950.3.6.365. [DOI] [PubMed] [Google Scholar]
  3. Bunting S., Gryglewski R., Moncada S., Vane J. R. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. Prostaglandins. 1976 Dec;12(6):897–913. doi: 10.1016/0090-6980(76)90125-8. [DOI] [PubMed] [Google Scholar]
  4. CAEN J., PARQUET-GERNEZ A. [Corticotherapy in prolonged bleeding time]. Nouv Rev Fr Hematol. 1963 May-Jun;3:355–361. [PubMed] [Google Scholar]
  5. Cade J., Hirsh J., Regoeczi E. Mechanisms for elevated fibrin/fibrinogen degradation products in acute experimental pulmonary embolism. Blood. 1975 Apr;45(4):563–568. [PubMed] [Google Scholar]
  6. Chandrabose K. A., Lapetina E. G., Schmitges C. J., Siegel M. I., Cuatrecasas P. Action of corticosteroids in regulation of prostaglandin biosynthesis in cultured fibroblasts. Proc Natl Acad Sci U S A. 1978 Jan;75(1):214–217. doi: 10.1073/pnas.75.1.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cottee F., Flower R. J., Moncada S., Salmon J. A., Vane J. R. Synthesis of 6-keto-PGF1alpha by ram seminal vesicle microsomes. Prostaglandins. 1977 Sep;14(3):413–423. doi: 10.1016/0090-6980(77)90257-x. [DOI] [PubMed] [Google Scholar]
  8. FALOON W. W., GREENE R. W., LOZNER E. L. The hemostatic defect in thrombocytopenia as studied by the use of ACTH and cortisone. Am J Med. 1952 Jul;13(1):12–20. doi: 10.1016/0002-9343(52)90076-4. [DOI] [PubMed] [Google Scholar]
  9. Famaey J. P., Fontaine J., Reuse J. Effect of high concentrations of non-steroidal and steroidal antiinflammatory drugs on prostaglandin-induced contractions of the guinea-pig isolated ileum. Prostaglandins. 1977 Jan;13(1):107–114. doi: 10.1016/0090-6980(77)90047-8. [DOI] [PubMed] [Google Scholar]
  10. Grodzińska L., Dembińska-Kieć A. Hydrocortisone and the release of prostaglandins from spleen. Prostaglandins. 1977 Jan;13(1):125–129. doi: 10.1016/0090-6980(77)90049-1. [DOI] [PubMed] [Google Scholar]
  11. Gruetter C. A., McNamara D. B., Hyman A. L., Kadowitz P. J. Contractile responses of intrapulmonary vessels from three species to arachidonic acid and an epoxymethano analog of PGH2. Can J Physiol Pharmacol. 1978 Apr;56(2):206–215. doi: 10.1139/y78-030. [DOI] [PubMed] [Google Scholar]
  12. Gryglewski R. J., Bunting S., Moncada S., Flower R. J., Vane J. R. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins. 1976 Nov;12(5):685–713. doi: 10.1016/0090-6980(76)90047-2. [DOI] [PubMed] [Google Scholar]
  13. Hong S. L., Levine L. Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids. Proc Natl Acad Sci U S A. 1976 May;73(5):1730–1734. doi: 10.1073/pnas.73.5.1730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hong S. L., Levine L. Stimulation of prostaglandin synthesis by bradykinin and thrombin and their mechanisms of action on MC5-5 fibroblasts. J Biol Chem. 1976 Sep 25;251(18):5814–5816. [PubMed] [Google Scholar]
  15. Kitchens C. S. Amelioration of endothelial abnormalities by prednisone in experimental thrombocytopenia in the rabbit. J Clin Invest. 1977 Nov;60(5):1129–1134. doi: 10.1172/JCI108864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lewis G. P., Piper P. J. Inhibition of prostaglandin release by antiinflammatory steroids. Adv Prostaglandin Thromboxane Res. 1976;1:121–124. [PubMed] [Google Scholar]
  17. Lewis G. P., Piper P. J. Inhibition of release of prostaglandins as an explanation of some of the actions of anti-inflammatory corticosteroids. Nature. 1975 Mar 27;254(5498):308–311. doi: 10.1038/254308a0. [DOI] [PubMed] [Google Scholar]
  18. MULDER E. The treatment of idiopathic thrombocytopenic purpura with ACTH and adrenal steroids. Ann Paediatr. 1962;198:401–413. [PubMed] [Google Scholar]
  19. MacIntyre D. E., Pearson J. D., Gordon J. L. Localisation and stimulation of prostacyclin production in vascular cells. Nature. 1978 Feb 9;271(5645):549–551. doi: 10.1038/271549a0. [DOI] [PubMed] [Google Scholar]
  20. Maca R. D., Fry G. L., Hoak J. C. The effects of glucocorticoids on cultured human endothelial cells. Br J Haematol. 1978 Apr;38(4):501–509. doi: 10.1111/j.1365-2141.1978.tb01075.x. [DOI] [PubMed] [Google Scholar]
  21. Needleman P., Bronson S. D., Wyche A., Sivakoff M., Nicolaou K. C. Cardiac and renal prostaglandin I2. Biosynthesis and biological effects in isolated perfused rabbit tissues. J Clin Invest. 1978 Mar;61(3):839–849. doi: 10.1172/JCI108998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Needleman P., Kulkarni P. S., Raz A. Coronary tone modulation: formation and actions of prostaglandins, endoperoxides, and thromboxanes. Science. 1977 Jan 28;195(4276):409–412. doi: 10.1126/science.831285. [DOI] [PubMed] [Google Scholar]
  23. Nijkamp F. P., Flower R. J., Moncada S., Vane J. R. Partial purification of rabbit aorta contracting substance-releasing factor and inhibition of its activity by anti-inflammatory steroids. Nature. 1976 Oct 7;263(5577):479–482. doi: 10.1038/263479a0. [DOI] [PubMed] [Google Scholar]
  24. STEFANINI M., PEREZ SANTIAGO E., CHATTERJEA J. B., DAMESHEK W., SALOMON L. Corticotropin and cortisone in idiopathic thrombocytopenic purpura. J Am Med Assoc. 1952 Jun 14;149(7):647–653. doi: 10.1001/jama.1952.02930240025009. [DOI] [PubMed] [Google Scholar]
  25. Smith J. B., Willis A. L. Aspirin selectively inhibits prostaglandin production in human platelets. Nat New Biol. 1971 Jun 23;231(25):235–237. doi: 10.1038/newbio231235a0. [DOI] [PubMed] [Google Scholar]
  26. Tashjian A. H., Jr, Voelkel E. F., McDonough J., Levine L. Hydrocortisone inhibits prostaglandin production by mouse fibrosarcoma cells. Nature. 1975 Dec 25;258(5537):739–741. doi: 10.1038/258739a0. [DOI] [PubMed] [Google Scholar]
  27. Thong K. L., Mant M. J., Grace M. G. Lack of effect of prednisone administration on bleeding time and platelet function of normal subjects. Br J Haematol. 1978 Mar;38(3):373–380. doi: 10.1111/j.1365-2141.1978.tb01057.x. [DOI] [PubMed] [Google Scholar]
  28. Weksler B. B., Marcus A. J., Jaffe E. A. Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells. Proc Natl Acad Sci U S A. 1977 Sep;74(9):3922–3926. doi: 10.1073/pnas.74.9.3922. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES